2Firsts Talks with Nancy Loucas, Asia-Pacific THR Leader: Giving a Voice to the Overlooked Consumer

Jun.18.2025
Ahead of the upcoming Global Forum on Nicotine (GFN), 2Firsts interviews Nancy Loucas, Executive Coordinator of CAPHRA, on why consumers must have a voice in tobacco harm reduction policymaking—and how she’s helping them speak up.

[By Taco Tuinstra | 2Firsts] Nancy Loucas: Helping Consumers Find Their Voice

 

As part of its media partnership with the Global Forum on Nicotine (GFN), scheduled for June 19-21 in Warsaw, 2Firsts reached out to several scheduled speakers, and asked them about their respective fields of expertise.

 

Nancy Loucas has been fighting for vapers’ rights to be able to access the tools they need to become smokefree and remain smoke free since 2015, when she co-founded the Aotearoa Vapers Community Advocacy in New Zealand.

 

She is also the executive director of the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), which supports consumer tobacco harm reduction (THR) advocacy organizations and activities throughout the Asia Pacific region and beyond.

 

Under Loucas’ leadership, CAPHRA established numerous initiatives to give a voice to the consumer, who she says is often overlooked in the debates. Such programs include the “Right2Vape” testimonial database (set up in collaboration with the Consumer Advocates for Smoke-free Alternatives Association in the United States) and the “Right2Switch” petition, which urges the World Health Organization to regulate based on science and include consumers into its decision-making process.

 

At the GNF, Loucas will be hosting a workshop to help consumers effectively communicate their message, which fits well with the overall conference theme of “Challenging Perceptions – Effective Communication for Tobacco Harm Reduction.” 2Firsts asked Loucas about her aspirations and the challenges facing consumers.

 

2Firsts Talks with Nancy Loucas, Asia-Pacific THR Leader: Giving a Voice to the Overlooked Consumer

Nancy Loucas | Image: AVCA

 

2Firsts: What inspired you to become a consumer advocate in the THR field?

 

Loucas: Watching relatives become ill and eventually die from smoking-related diseases. Watching relatives not receive appropriate medical care for nonsmoking-related illnesses, because of their smoking status. Not wanting my children to lose their mother, as I lost mine from smoking, at an early age. Wanting others to have the same opportunity I had to move off the deadly stuff.

 

2Firsts: How do you define THR, and why is the consumer perspective essential in this space?

 

Loucas: Short answer: My definition of THR is saving lives with innovation. Long answer: It is the prevention of smoking related death and disease through the use of innovative nicotine products that help people to move away from smoking and unsafe oral tobacco use.

 

2Firsts: What challenges do consumers face in communicating their positions?

 

Loucas: The main challenge is being listened to. The Machine, as I like to call tobacco control, likes to denigrate and dehumanize consumers and their lived experiences by labeling them as “anecdotes,” as opposed to scientists, experts or researchers. They do this by calling us names, accusing us of nefarious activities to the benefit of tobacco companies, and [by] excluding us from a seat at the table.

 

Another challenge arises from external NGO's [nongovernmental organizations] coming into countries without actually caring about that country, its culture or its problems, but only wanting to control the narrative with their views, their solutions, their policies. In Asia Pacific, a western mindset doesn't translate well at all.

 

2Firsts:What strategies have you found effective in elevating consumer perspectives in regulatory or scientific arenas?

 

Loucas:The one really good thing about the wider THR community is that the consumers, scientists and some regulatory people do communicate with respect and consideration. At conferences, everyone engages; the pro-THR scientists treat the consumers as equals.

 

In Asia Pacific—with the exception of Australia and India—there's less of a barrier between advocates on the one hand and public health and/or government on the other. That could be due to a number of factors, but I think it's mainly about networking in collective societies. Asia Pacific folks aren't very individualistic and going on about “my rights as an individual.” There are consumers who are on government committees about regulation; there are consumers who regularly engage with regulatory folks on a personal level.

 

The elevation of the consumer perspective is not so much the issue as is the backlash and misinformation from externally funded tobacco control-NGOs pushing a scripted narrative.

 

2Firsts:In your view, how can consumers be meaningfully involved in policy development on nicotine and tobacco products?

 

Loucas:Consumers can be—and should be—meaningfully involved in policy development as the decisions made directly impact them. The best way to do that is to engage. Some consumers are afraid they do not have the skills or the “right” to speak to policy/public health/government people, but with some support, some training and focus, they are the kingmakers really. My main comment to consumers who are reticent to engage is this "elected officials work for you, not the other way around.”

 

2Firsts:What are the primary benefits you hope participants will gain from your GFN workshop?

 

Loucas:The GFN is about learning, community and support. The workshop is about helping people succeed in their advocacy and feel supported and confident in their mission.

 

2Firsts has been a media partner of the Global Forum on Nicotine (GFN) for three consecutive years.


2Firsts welcomes article submissions, interview opportunities, or commentary. Please contact us at info@2firsts.com or connect with 2Firsts CEO Alan Zhao on LinkedIn here.

 

PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24
Nearly Half of Seoul Vape Vending Machines Bypassed by Fake IDs, Raising Youth Access Concerns
Nearly Half of Seoul Vape Vending Machines Bypassed by Fake IDs, Raising Youth Access Concerns
Seoul city authorities inspected 339 tobacco vending machines at e-cigarette retailers and found that 168, or 49.5%, allowed purchases using fake IDs, showing that unmanned retail terminals and adult-verification systems remain a major enforcement gap after e-cigarettes were brought under tobacco regulation.
Market
Jul.03 by 2Firsts Perspectives
AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
Nasdaq-listed AIR Global has invested $20 million in preferred shares of Canadian vaporization technology company Greentank, deepening a partnership established in 2023. AIR gains a board nomination right, access to new technologies, enhanced commercial terms and long-term supply assurances, while retaining an option to increase its stake. Greentank’s Quantum Chip platform powers Crown Switch and forms part of AIR’s planned U.S. PMTA dossier, linking capital investment more closely with product technology, regulatory evidence and supply-chain control.
Special Report
Jul.29
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa
Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa
KT&G has introduced nicotine pouch brand LOOP in South Africa, expanding its modern oral nicotine portfolio. Developed by Swedish company Another Snus Factory (ASF), LOOP is a tobacco-free nicotine pouch brand. KT&G and U.S. tobacco company Altria previously participated in ASF’s strategic development, and the South Africa launch represents a further step in LOOP’s international expansion.
Aug.06
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
Philip Morris Japan (PMJ) announced that it will open “IQOS Flagship Ginza” in Tokyo on September 4, 2026. The location will become the first global flagship space for PMI’s IQOS brand. PMJ said the venue will target adult smokers aged 20 and above and combine product experiences, community engagement and local cultural elements. The design will incorporate Japanese natural aesthetics and traditional craftsmanship. The launch reflects PMI’s broader strategy of strengthening consumer engagement through experiential retail and brand spaces. The existing IQOS Store Ginza is scheduled to close on August 30, 2026.
Jul.21